logo

Arcturus Therapeutics Holdings Inc (ARCT) Stock: Uncovering 52-Week Market Trends

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Arcturus Therapeutics Holdings Inc’s current trading price is -36.91% away from its 52-week high, while its distance from the 52-week low is 57.76%. The stock’s price range for this time frame has been between $17.52 and $43.81. The trading volume of the company’s shares in the Healthcare reached around 0.61 million for the day, which was evidently higher than the average daily volume of 0.47 million over the last three months.

Arcturus Therapeutics Holdings Inc’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $43.81 on 02/27/24, and the lowest price during that time was $17.52, recorded on 11/13/23.

How Financial Performance Impacts Market Capitalization

Arcturus Therapeutics Holdings Inc (ARCT) has experienced a quarterly decline of -14.82% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 744.07M and boasts a workforce of 180 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 32.71, with a change in price of +4.70. Similarly, Arcturus Therapeutics Holdings Inc recorded 448,191 in trading volume during the last 100 days, posting a change of +20.49%.

How ARCT’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for ARCT stands at 0.11. Similarly, the long-term debt-to-equity ratio is also 0.09.

ARCT Stock Stochastic Average

The raw stochastic average for Arcturus Therapeutics Holdings Inc over the last 50 days is presently at 1.07%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 2.13%. Further, the company’s Stochastic %K and %D values for the last 20 days were 8.19% and 11.60%, respectively.

ARCT Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The metric has seen a significant loss of -12.34% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 21.98%. Over the past 30 days, the price of ARCT has leaped by -16.57%. And in the last five days, it has fallen by -13.19%.